Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer.
Cavalleri T, Greco L, Rubbino F, Hamada T, Quaranta M, Grizzi F, Sauta E, Craviotto V, Bossi P, Vetrano S, Rimassa L, Torri V, Bellazzi R, Mantovani A, Ogino S, Malesci A, Laghi L. Cavalleri T, et al. J Pathol Clin Res. 2022 Jul;8(4):307-312. doi: 10.1002/cjp2.267. Epub 2022 Mar 23. J Pathol Clin Res. 2022. PMID: 35318822 Free PMC article.
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.
Malesci A, Bianchi P, Celesti G, Basso G, Marchesi F, Grizzi F, Di Caro G, Cavalleri T, Rimassa L, Palmqvist R, Lugli A, Koelzer VH, Roncalli M, Mantovani A, Ogino S, Laghi L. Malesci A, et al. Among authors: cavalleri t. Oncoimmunology. 2017 Jul 12;6(12):e1342918. doi: 10.1080/2162402X.2017.1342918. eCollection 2017. Oncoimmunology. 2017. PMID: 29209561 Free PMC article.
Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression.
Cavalleri T, Bianchi P, Basso G, Celesti G, Grizzi F, Bossi P, Greco L, Pitrone C, Valtorta E, Mauri G, Truini M, Dall'Olio FG, Brandi G, Sartore-Bianchi A, Ricciardiello L, Torri V, Rimassa L, Siena S, Mantovani A, Malesci A, Laghi L; Alleanza contro il Cancro (ACC) Colorectal Cancer Working Group. Cavalleri T, et al. Cancer Immunol Res. 2019 May;7(5):751-758. doi: 10.1158/2326-6066.CIR-18-0661. Epub 2019 Feb 25. Cancer Immunol Res. 2019. PMID: 30804005 Free article.
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer.
Petti L, Rizzo G, Rubbino F, Elangovan S, Colombo P, Restelli S, Piontini A, Arena V, Carvello M, Romano B, Cavalleri T, Anselmo A, Ungaro F, D'Alessio S, Spinelli A, Stifter S, Grizzi F, Sgambato A, Danese S, Laghi L, Malesci A, Vetrano S. Petti L, et al. Among authors: cavalleri t. J Exp Clin Cancer Res. 2020 Nov 23;39(1):253. doi: 10.1186/s13046-020-01740-6. J Exp Clin Cancer Res. 2020. PMID: 33225975 Free PMC article.
Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
Cavalleri T, Angelici L, Favero C, Dioni L, Mensi C, Bareggi C, Palleschi A, Rimessi A, Consonni D, Bordini L, Todaro A, Bollati V, Pesatori AC. Cavalleri T, et al. PLoS One. 2017 May 4;12(5):e0176680. doi: 10.1371/journal.pone.0176680. eCollection 2017. PLoS One. 2017. PMID: 28472171 Free PMC article.
Blood DNA methylation, nevi number, and the risk of melanoma.
Pergoli L, Favero C, Pfeiffer RM, Tarantini L, Calista D, Cavalleri T, Angelici L, Consonni D, Bertazzi PA, Pesatori AC, Landi MT, Bollati V. Pergoli L, et al. Among authors: cavalleri t. Melanoma Res. 2014 Oct;24(5):480-7. doi: 10.1097/CMR.0000000000000112. Melanoma Res. 2014. PMID: 25026000 Free PMC article.
14 results